Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Centene Corporation (CNC:NYSE), powered by AI.
Centene Corporation is currently trading at $65.19. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Centene Corporation on Alpha Lenz.
Centene Corporation's P/E ratio is -4.8.
“Centene Corporation trades at a P/E of -4.8 (undervalued) with modest ROE of -28.8%. 3Y revenue CAGR of 10.5% highlights clear growth momentum.”
Ask for details →Centene Corporation is a diversified healthcare enterprise providing a comprehensive range of managed care services to government-sponsored healthcare programs. Specializing in serving uninsured and underinsured populations, Centene offers health plans, benefits management, and other related services. It operates through two primary segments: Managed Care and Specialty Services. The Managed Care segment provides health plan coverage to individuals through Medicaid, Medicare Advantage, and the Health Insurance Marketplace, impacting millions of lives across the United States. Meanwhile, the Specialty Services segment enhances healthcare quality and affordability through offerings such as pharmacy solutions, behavioral health, and optometry services. Founded in 1984 and headquartered in St. Louis, Missouri, Centene plays a significant role in the healthcare sector by addressing accessibility and cost challenges, thereby shaping market trends and influencing policy developments. As a major participant in the managed care industry, Centene is crucial for promoting coordinated care and improving health outcomes for vulnerable populations.
“Centene Corporation trades at a P/E of -4.8 (undervalued) with modest ROE of -28.8%. 3Y revenue CAGR of 10.5% highlights clear growth momentum.”
Ask for details →Centene Corporation (ticker: CNC) is a company listed on NYSE in the Healthcare sector (Healthcare Plans). It has approximately 60,500 employees. Market cap is $32.1B.
The current price is $65.19 with a P/E ratio of -4.82x and P/B of 1.61x.
ROE is -28.79% and operating margin is -0.16%. Annual revenue is $194.8B.